Ferrante M, Feagan BG, Panes J, Baert F, et al. Long-Term Safety and Efficacy of Risankizumab Treatment in Patients with Crohn's Disease: Results from the Phase 2 Open-Label Extension Study. J Crohns Colitis 2021;15:2001-2010.
PMID: 34077509